Samsung Introduces Lunit AI Solutions for Enhanced Chest Screenings
This launch aims to elevate chest abnormality detection in Samsung’s premium X-ray devices and help clinicians provide a more efficient care path for patients
Boston Imaging, the United States headquarters of Samsung’s digital radiography (DR) and ultrasound business, announced that Samsung has signed a supply contract with Lunit Inc., a leading provider of artificial intelligence (AI) powered solutions for cancer diagnostics and therapeutics, to enable faster and more accurate chest screenings for timely interventions with improved patient outcomes.
“As advanced technologies deliver improved patient outcomes and cost savings in healthcare, our digital radiography flagship products GM85 and GC85A Vision are at the forefront of that innovation, advancing healthcare imaging with features such as “Vision Assist”
The Lunit INSIGHT CXR, an AI-powered chest X-ray analysis solution, and Lunit Insight CXR Triage, an FDA 510(k)-cleared AI triage solution for critical chest findings, will enable Samsung’s CAD (Computer Aided Detection) AI to help radiologists manage the unprecedented volume of patient exams by prioritizing those with suspected abnormalities.
Recommended AI News: Zendesk Boasts 43 Percent Lower Total Cost of Ownership than Salesforce: Insights from Nucleus Research Report
“Chest X-rays are still today the most requested exam in radiography,” said Eric Sumner, Head of Digital Radiography. “As part of our voice of customer initiatives, we are building on our prior offering of auto lung nodule detection (ALND) by integrating new on-device, real-time artificial intelligence technologies. By partnering with Lunit, our Samsung digital radiology products will now have computer-assisted triage and notification software that analyzes adult chest X-ray images for the presence of suspected pleural effusion or pneumothorax. Patients with suspected findings will move to the top of the radiologist queue, allowing patients to be diagnosed more quickly. This will provide critical information to radiologists as they triage urgent cases.”
Over the past two years, Samsung has made significant investments to bring best-in-class technology to radiology leaders and administration ensuring more enhanced patient care and workflow efficiency while maintaining a low-dose imaging experience.
Recommended AI News: Versa Networks Launches Industry’s First Unified SASE Gateway that Scales Beyond 100 Gbps
“As advanced technologies deliver improved patient outcomes and cost savings in healthcare, our digital radiography flagship products GM85 and GC85A Vision are at the forefront of that innovation, advancing healthcare imaging with features such as “Vision Assist” and AccE Glass Free Detector,” said David Legg, Head of Boston Imaging. “With innovation as its cornerstone, Samsung continues to drive solutions to provide excellent patient experiences, simplify technologist workflows and aid in faster diagnosis. We are proud that the addition of Lunit’s AI-powered solutions will further radiologists’ abilities to provide efficient and comprehensive patient care.”
The Lunit AI solution software is commercially available on Samsung digital radiology products as of Q1 2024.1 As part of the collaboration with Lunit, Samsung will continue to expand on validating the AI solution to detect the 10 most common abnormalities in Chest X-ray including nodule, pneumothorax, atelectasis, cardiomegaly, calcification, consolidation, pleural effusion, pneumoperitoneum, mediastinal widening, fibrosis and support tuberculosis screening.
Samsung will offer the upgraded systems to North America and European markets and to the Middle East, South America and Southeast Asia.
Recommended AI News: Deutsche Telekom Awards Mavenir Cloud-Native Messaging Contracts Driving 5G Readiness Across Four Networks
[To share your insights with us as part of editorial or sponsored content, please write to sghosh@martechseries.com]
Comments are closed.